Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

DSM And North China Sign Antibiotics Pact

by Michael McCoy
March 23, 2009 | A version of this story appeared in Volume 87, Issue 12

DSM has signed contracts with North China Pharmaceutical Group Co. regarding the establishment of three joint ventures in the areas of nutritional products and anti-infectives. DSM will buy a 10% stake in NCPC. The two firms will form a vitamin C joint venture in which DSM holds a 30% stake and two bulk antibiotics joint ventures, each 51% owned by DSM. In all, DSM will invest about $110 million. DSM has long sought a partner for its anti-infectives business. It signed a preliminary agreement with NCPC in 2004.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.